Karman Holdings Inc. (KRMN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Karman Holdings Inc. on January 7, 2026, reporting events occurring on December 31, 2025. The Company, incorporated in Delaware and listed on the New York Stock Exchange, is an emerging growth company. The filing primarily discloses a material acquisition agreement entered into at the end of 2025.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The only specific financial data disclosed relates to the transaction value of the acquisition:
- Total Consideration: $220,000,000
- Cash Component: $210,000,000
- Stock Component: $10,000,000 (aggregate value of common stock)
Material Changes
The primary material change is the execution of a Securities Purchase Agreement on December 31, 2025. Under this agreement, a wholly-owned subsidiary of Karman Holdings agreed to acquire Seemann Composites, LLC and Materials Sciences LLC (collectively, the "Company Group"). The transaction is subject to customary purchase price adjustments and closing conditions, including the expiration of the Hart-Scott-Rodino Antitrust waiting period.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond standard closing conditions. The transaction is contingent upon the satisfaction or waiver of customary closing conditions. The press release associated with this filing is incorporated by reference but is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the closing status of the $220 million acquisition of Seemann Composites and Materials Sciences.
- Confirm the impact of the $210 million cash outlay on the Company's current liquidity and debt covenants.
- Monitor the status of the Hart-Scott-Rodino Antitrust waiting period as a condition for closing.
- Review the specific terms of the purchase price adjustments and the dilution impact of the $10 million stock issuance.